Molecular vulnerabilities and therapeutic resistance in hormone receptor positive and HER2 dependent breast cancer tumours.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ravi,Velaga

第一单位： Breast Surgery, Graduate School of Medicine, Kyoto University Hospital, Kyoto University, 54 Shogoin-Kawaracho, Sakyo-ku, Kyoto 606-8507, Japan.

作者： Ravi,Velaga ^[1] ; Sunao,Tanaka ^[1] ; Masakazu,Toi ^[1]

作者单位： Breast Surgery, Graduate School of Medicine, Kyoto University Hospital, Kyoto University, 54 Shogoin-Kawaracho, Sakyo-ku, Kyoto 606-8507, Japan. ^[1]

关键词 CDK4/6 HER2 HER2 and HER3 co-mutations JNK pathway MONALESSA-2 trial drug resistance hot and cold tumour microbiome

DOI 10.20517/cdr.2022.10

PMID 35800379

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer drug resistance (Alhambra, Calif.)

2022年5卷2期

487-497页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Molecular vulnerabilities and therapeutic resistance in hormone receptor positive and HER2 dependent breast cancer tumours.

Cancer drug resistance (Alhambra, Calif.)

相似文献

Cancer drug resistance (Alhambra, Calif.)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Molecular vulnerabilities and therapeutic resistance in hormone receptor positive and HER2 dependent breast cancer tumours.

Cancer drug resistance (Alhambra, Calif.)

相似文献

Cancer drug resistance (Alhambra, Calif.)

相关期刊

检索历史清除